Skip to content

Medical-device intelligence

OZN: C. Difficile Toxin Gene Amplification Assay

FDA product code OZN: C. Difficile Toxin Gene Amplification Assay. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OZN
FDA device name
C. Difficile Toxin Gene Amplification Assay
Device class
2
Regulation number
866.3130
Medical specialty
Microbiology
Review panel
MI

FDA definition

Amplification assay for the detection of c. Difficile toxin genes from stool specimens of symptomatic patients.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

18 clearance records and 8 recall records in the covered releases, across 15 source company names and 1 product codes. Dated history runs from Dec 5, 2012 to Aug 28, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202501
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202610
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OZN · C. Difficile Toxin Gene Amplification Assay188

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

26 matching records
Device / recordCompany in FDA recordSourceSource date
cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative Control Kit for use on the co…K260045 · OZNRoche Molecular Systems, Inc.510(k)Aug 28, 2026FDA decision date
Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300Z-1019-2026 · OZNMeridian Bioscience IncRecallJan 5, 2026FDA classification date
BD MAX System, for in vitro diagnostic (IVD) use, labeled as the following: 1. BD MAX System, BD MAX Instrument, Catalog Numbers: 44191609, 4419…Z-0238-2026 · OZNBecton Dickinson & Co.RecallOct 23, 2025FDA classification date
Xpert C. difficile/EpiK243730 · OZNCepheid®510(k)Feb 28, 2025FDA decision date
BD MAX System, BD MAX Instrument Version or Model: 441916 Catalog Number: 441916Z-0590-2025 · OZNBecton Dickinson & Co.RecallDec 3, 2024FDA classification date
Great Basin Toxigenic C. difficile Direct Test (CDF2)K232092 · OZNVela Operations USA510(k)Nov 14, 2023FDA decision date
VERIGENE Clostridium difficile Nucleic Acid Test, REF 30-002-022Z-2024-2023 · OZNLuminex CorporationRecallJun 28, 2023FDA classification date
Verigene CDF Nucleic Acid Test, Part No. 30-002-22Z-1334-2022 · OZNLuminex CorporationRecallJul 6, 2022FDA record creation date
cobas Cdiff nucleic acid test for use on the cobas Liat SystemK212427 · OZNRoche Molecular Systems, Inc.510(k)Oct 20, 2021FDA decision date
cobas Cdiff nucleic acid test for use on the cobas Liat SystemK210385 · OZNRoche Molecular Systems, Inc.510(k)Sep 9, 2021FDA decision date
ARIES C. difficile Assay , REF 50-10018, UDI # 00840487100059Z-2287-2019 · OZNLuminex CorporationRecallAug 15, 2019FDA classification date
GenePOC CDiffK172569 · OZNGenepoc, Inc.510(k)Nov 22, 2017FDA decision date
cobas Cdiff Nucleic acid test for use on the cobas Liat SystemK171770 · OZNRoche Molecular Systems, Inc.510(k)Sep 12, 2017FDA decision date
ARIES C. difficile Assay Complete Kit, ARIES C. difficile Assay Protocol File Kit, ARIES C. difficile Assay Kit (24 cassettes), ARIES Stool Resus…K171441 · OZNLuminex Corporation510(k)Jul 21, 2017FDA decision date
Solana C. difficile AssayK170491 · OZNQuidel Corporation510(k)May 11, 2017FDA decision date
Simplexa C. difficile Direct; Simplexa C. difficile Positive Control PackK163085 · OZNFocus Diagnostics, Inc.:Dba Diasorin Molecular, LLC510(k)Feb 14, 2017FDA decision date
cobas Cdiff TestK142422 · OZNRoche Molecular Systems, Inc.510(k)May 20, 2015FDA decision date
The Verigene Clostridium difficile Nucleic Acid Test (CDF) is a qualitative, multiplexed in vitro diagnostic test for the rapid detection of toxi…Z-2682-2014 · OZNNanosphere, Inc.RecallSep 23, 2014FDA classification date
Nanosphere Verigene Each CDF test consists of a Verigene CDF Nucleic Acid Test Kit and a Verigene CDF Amplification Reagent Kit. The Veri…Z-2168-2014 · OZNNanosphere, Inc.RecallAug 8, 2014FDA classification date
ARTUS C. DIFFICILE QS-RGQ MDX KITK133936 · OZNQIAGEN GmbH510(k)Apr 4, 2014FDA decision date
ICEPLEX C. DIFFICILE ASSAY KIT, ICEPLEX SYSTEMK132726 · OZNPrimeradx510(k)Nov 29, 2013FDA decision date
IMDX C.DIFFICILE FOR ABBOTT M2000K132235 · OZNIntelligent Medical Devices, Inc.510(k)Oct 11, 2013FDA decision date
BD MAX CDIFF ASSAY, BD MAX INSTRUMENTK130470 · OZNGeneohm Sciences Canada, Inc. (Bd Diagnostics)510(k)Apr 2, 2013FDA decision date
QUIDEL MOLECULAR DIRECT C. DIFFICILE ASSAYK123998 · OZNQuidel Corp.510(k)Mar 8, 2013FDA decision date
AMPLIVUE C. DIFFICILE ASSAYK123355 · OZNQuidel Corporation510(k)Dec 13, 2012FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗